Cargando…

FFA4/GPR120: Pharmacology and Therapeutic Opportunities

Free Fatty Acid receptor 4 (FFA4), also known as GPR120, is a G-protein-coupled receptor (GPCR) responsive to long-chain fatty acids that is attracting considerable attention as a potential novel therapeutic target for the treatment of type 2 diabetes mellitus (T2DM). Although no clinical studies ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milligan, Graeme, Alvarez-Curto, Elisa, Hudson, Brian D., Prihandoko, Rudi, Tobin, Andrew B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published By Elsevier In Association With The International Union Of Pharmacology 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582618/ https://www.ncbi.nlm.nih.gov/pubmed/28734639 http://dx.doi.org/10.1016/j.tips.2017.06.006

Ejemplares similares

Concomitant Action of Structural Elements and Receptor Phosphorylation Determines Arrestin-3 Interaction with the Free Fatty Acid Receptor FFA4
por: Butcher, Adrian J., et al.
Publicado: (2014)

The Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)
por: Hudson, Brian D., et al.
Publicado: (2014)

Development of Free Fatty Acid Receptor 4 (FFA4/GPR120) Agonists in Health Science
por: Son, So-Eun, et al.
Publicado: (2021)

Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling
por: Alvarez-Curto, Elisa, et al.
Publicado: (2016)

Probe-Dependent Negative Allosteric Modulators of the Long-Chain Free Fatty Acid Receptor FFA4
por: Watterson, Kenneth R., et al.
Publicado: (2017)

Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35
por: Quon, Tezz, et al.
Publicado: (2020)

Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets
por: Ulven, Trond
Publicado: (2012)

Extracellular Ionic Locks Determine Variation in Constitutive Activity and Ligand Potency between Species Orthologs of the Free Fatty Acid Receptors FFA2 and FFA3
por: Hudson, Brian D., et al.
Publicado: (2012)

Selective Orthosteric Free Fatty Acid Receptor 2 (FFA2) Agonists: IDENTIFICATION OF THE STRUCTURAL AND CHEMICAL REQUIREMENTS FOR SELECTIVE ACTIVATION OF FFA2 VERSUS FFA3
por: Schmidt, Johannes, et al.
Publicado: (2011)

Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases
por: Wannick, Melanie, et al.
Publicado: (2018)

Therapeutic validation of an orphan G protein‐coupled receptor: The case of GPR84
por: Marsango, Sara, et al.
Publicado: (2020)

Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes
por: Christiansen, Elisabeth, et al.
Publicado: (2013)

The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A
por: Bisenieks, Egils, et al.
Publicado: (2021)

Defining the Molecular Basis for the First Potent and Selective Orthosteric Agonists of the FFA2 Free Fatty Acid Receptor
por: Hudson, Brian D., et al.
Publicado: (2013)

Label-free cell phenotypic study of FFA4 and FFA1 and discovery of novel agonists of FFA4 from natural products
por: Xu, Fangfang, et al.
Publicado: (2019)

Pharmacological properties of acid N-thiazolylamide FFA2 agonists
por: Brown, Andrew J, et al.
Publicado: (2015)

Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor
por: Divorty, Nina, et al.
Publicado: (2022)

Allosteric targeting of the FFA2 receptor (GPR43) restores responsiveness of desensitized human neutrophils
por: Frei, Robert, et al.
Publicado: (2020)

GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery
por: Carullo, Gabriele, et al.
Publicado: (2021)

OR23-4 Intestinal FFA2 and FFA3 Mediate Obesogenic Effects in Mice on a Western Diet
por: Gough, Sophie, et al.
Publicado: (2022)

Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance
por: Houthuijzen, Julia M., et al.
Publicado: (2017)

G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes
por: Lin, Li-Chiung, et al.
Publicado: (2021)

Regulation of Energy Homeostasis via GPR120
por: Ichimura, Atsuhiko, et al.
Publicado: (2014)

Long Chain Fatty Acids as Modulators of Immune Cells Function: Contribution of FFA1 and FFA4 Receptors
por: Hidalgo, Maria A., et al.
Publicado: (2021)

Novel FFA1 (GPR40) agonists containing spirocyclic periphery: polar azine periphery as a driver of potency
por: Krasavin, Mikhail, et al.
Publicado: (2016)

GPR120 is an important inflammatory regulator in the development of osteoarthritis
por: Chen, Yuanfeng, et al.
Publicado: (2018)

AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in Rodents
por: Lin, Daniel C.-H., et al.
Publicado: (2011)

Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis
por: Carr, Zyad J., et al.
Publicado: (2018)

Delphinidin Reduces Glucose Uptake in Mice Jejunal Tissue and Human Intestinal Cells Lines through FFA1/GPR40
por: Hidalgo, Jorge, et al.
Publicado: (2017)

GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice
por: Zhao, Jie, et al.
Publicado: (2016)

EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4
por: Kamata, Ryo, et al.
Publicado: (2016)

GPR35 as a Novel Therapeutic Target
por: MacKenzie, A. E., et al.
Publicado: (2011)

Potential roles of GPR120 and its agonists in the management of diabetes
por: Zhang, Dan, et al.
Publicado: (2014)

GPR120 promotes neutrophil control of intestinal bacterial infection
por: Zhou, Zheng, et al.
Publicado: (2023)

Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023)

G protein‐coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35
por: Milligan, Graeme
Publicado: (2017)

Distinct Agonist Regulation of Muscarinic Acetylcholine M(2)-M(3) Heteromers and Their Corresponding Homomers
por: Aslanoglou, Despoina, et al.
Publicado: (2015)

Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammation
por: Dragano, Nathalia R. V., et al.
Publicado: (2017)

The Role of GPR120 Receptor in Essential Fatty Acids Metabolism in Schizophrenia
por: Rog, Joanna, et al.
Publicado: (2020)

Muscarinic receptor oligomerization
por: Marsango, Sara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gg105rd2kon7noc460lb9b6c5j